Skip to main content
. 2022 Dec 15;17(1):1641–1656. doi: 10.1515/biol-2022-0102

Figure 2.

Figure 2

The role of EPCs in cancer. (1) Tumors promote the expansion of EPCs and (2) tumors inhibit the maturation and differentiation of EPCs. Early CD45+ EPCs use (a) TGF-β, (b) ROS, (c) IL-10 and (d) PD-L1 regulates immune responses. More mature CD45 EPCs regulate cancer progression through (e) secretion of Artemin.